Spots Global Cancer Trial Database for xyotax
Every month we try and update this database with for xyotax cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) | NCT00487669 | Advanced Non-sm... | paclitaxel poli... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer | NCT00270907 | Metastatic Brea... Breast Cancer | CT-2103 Gemcitabine | 18 Years - | M.D. Anderson Cancer Center | |
Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | NCT00148707 | Breast Cancer Metastatic Brea... | CT-2103 (Xyotax... | 18 Years - | Dana-Farber Cancer Institute |